Open AccessStimulant Therapy Utilization for Neurocognitive Deficits in Mild Traumatic Brain Injury
Author(s) -
Eric E. Coris,
Byron Moran,
Kevin B. Sneed,
Gianluca Del Rossi,
Bradford Bindas,
Shaan Mehta,
Dusty Marie Narducci
Publication year - 2021
Publication title -
sports health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.212
H-Index - 44
eISSN - 1941-7381
pISSN - 1941-0921
DOI - 10.1177/19417381211031842
Subject(s) - neurocognitive , stimulant , traumatic brain injury , attention deficit hyperactivity disorder , psychiatry , medicine , clinical psychology , psychology , context (archaeology) , cognition , paleontology , biology
There are 3.8 million mild traumatic brain injuries (mTBIs) that occur each year in the United States. Many are left with prolonged life-altering neurocognitive deficits, including difficulties in attention, concentration, mental fatigue, and distractibility. With extensive data on the safety and efficacy of stimulant medications in treating attention deficit, concentration difficulties and distractibility seen with attention deficit disorder, it is not surprising that interest continues regarding the application of stimulant medications for the persistent neurocognitive deficits in some mTBIs.